Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise D'Huart

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
European Journal of Hospital Pharmacy : Science and Practice|February 18, 2020
Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bagsElise D'Huart, Jean Vigneron, Pauline Lider, et al.
European Journal of Hospital Pharmacy : Science and Practice|March 20, 2023
A new function in the Stabilis database: physical compatibility and incompatibility of injectable drugs to secure Y-site administrationBenoît Beiler, Jean Vigneron, Elise D'Huart, et al.
European Journal of Hospital Pharmacy : Science and Practice|April 17, 2020
Physicochemical stability of nefopam and nefopam/droperidol solutions in polypropylene syringes for intensive care unitsElise D'Huart, Jean Vigneron, Igor Clarot, et al.
European Journal of Hospital Pharmacy : Science and Practice|October 21, 2020
High concentrated etoposide solutions, additional physical stability data in dextrose 5Marine Ravey, Caroline Polo, Elise D'Huart, et al.
European Journal of Hospital Pharmacy : Science and Practice|August 19, 2021
Physicochemical stability of cefiderocol, a novel siderophore cephalosporin, in syringes at 62.5 mg/mL for continuous administration in intensive care unitsGuillaume Loeuille, Jean Vigneron, Elise D'Huart, et al.
European Journal of Hospital Pharmacy : Science and Practice|February 26, 2024
Physicochemical stability of pevonedistat at 50, 100 and 200 µg/mL diluted in 0.9% sodium chloride and at 10 mg/mL in partially used vialsRalitsa Doncheva, Elise D'Huart, Nathalie Sobalak, et al.
Annales Pharmaceutiques Francaises|July 12, 2025
[Incompatibility of injectable drugs in neonatal intensive care: From assessment to implementation of a preventive tool]Marie Guedon, Catherine Mennesson, Baptiste Fulbert, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 30, 2024
Evaluation of parenteral diluent contamination by caprolactamChristophe Curti, Elise D'Huart, Edouard Lamy, et al.
European Journal of Hospital Pharmacy : Science and Practice|December 4, 2025
Physicochemical stability of the nefopam in elastomeric device at 0.2 and 3.33 mg/mLAline Daval, Elise D'Huart, Franck Blaise, et al.
Antibiotics (Basel, Switzerland)|April 23, 2022
Stability Studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial TherapyGuillaume Loeuille, Elise D'Huart, Jean Vigneron, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
European Journal of Hospital Pharmacy : Science and Practice|February 18, 2020
Physicochemical stability of etoposide diluted at range concentrations between 0.38 and 1.75 mg/mL in polyolefin bagsElise D'Huart, Jean Vigneron, Pauline Lider, et al.
European Journal of Hospital Pharmacy : Science and Practice|March 20, 2023
A new function in the Stabilis database: physical compatibility and incompatibility of injectable drugs to secure Y-site administrationBenoît Beiler, Jean Vigneron, Elise D'Huart, et al.
European Journal of Hospital Pharmacy : Science and Practice|April 17, 2020
Physicochemical stability of nefopam and nefopam/droperidol solutions in polypropylene syringes for intensive care unitsElise D'Huart, Jean Vigneron, Igor Clarot, et al.
European Journal of Hospital Pharmacy : Science and Practice|October 21, 2020
High concentrated etoposide solutions, additional physical stability data in dextrose 5Marine Ravey, Caroline Polo, Elise D'Huart, et al.
European Journal of Hospital Pharmacy : Science and Practice|August 19, 2021
Physicochemical stability of cefiderocol, a novel siderophore cephalosporin, in syringes at 62.5 mg/mL for continuous administration in intensive care unitsGuillaume Loeuille, Jean Vigneron, Elise D'Huart, et al.
European Journal of Hospital Pharmacy : Science and Practice|February 26, 2024
Physicochemical stability of pevonedistat at 50, 100 and 200 µg/mL diluted in 0.9% sodium chloride and at 10 mg/mL in partially used vialsRalitsa Doncheva, Elise D'Huart, Nathalie Sobalak, et al.
Annales Pharmaceutiques Francaises|July 12, 2025
[Incompatibility of injectable drugs in neonatal intensive care: From assessment to implementation of a preventive tool]Marie Guedon, Catherine Mennesson, Baptiste Fulbert, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|July 30, 2024
Evaluation of parenteral diluent contamination by caprolactamChristophe Curti, Elise D'Huart, Edouard Lamy, et al.
European Journal of Hospital Pharmacy : Science and Practice|December 4, 2025
Physicochemical stability of the nefopam in elastomeric device at 0.2 and 3.33 mg/mLAline Daval, Elise D'Huart, Franck Blaise, et al.
Antibiotics (Basel, Switzerland)|April 23, 2022
Stability Studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial TherapyGuillaume Loeuille, Elise D'Huart, Jean Vigneron, et al.
Pageof 2